» Articles » PMID: 33435562

The Impact of Radiotherapy on the Incidence of Secondary Malignancies: A Pan-Cancer Study in the US SEER Cancer Registries

Overview
Journal Curr Oncol
Publisher MDPI
Specialty Oncology
Date 2021 Jan 13
PMID 33435562
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

The population of cancer patients with second primary malignancies (SPMs) is rapidly growing. The relationship between radiotherapy and SPMs for some types of tumors is unknown or debated. In this study, we identify 24 types of first primary malignancies (FPMs) between 2004 and 2015 in the Surveillance, Epidemiology, and End Results (SEER) database. Patients in the radiotherapy group were matched to those in the no radiotherapy group with a matching ratio of 1:1. After propensity-score matching (PSM), additional competing risk regression analyses were performed to calculate the efficacy of radiotherapy to SPMs in the PSM-adjusted population. In addition, the Fine and Gray model was utilized in the primary cohorts, and stratified analyses were performed based on surgery. This study includes a total of 2,831,789 eligible patients with tumors diagnosed from 2004 to 2015 in the SEER 18 database, amongst whom 100,194 (3.5%) patients developed SPMs. We observe higher risks of SPMs associated with radiotherapy in several types of tumors in the PSM-adjusted populations (small bowel adenocarcinoma, small cell lung carcinoma, prostate adenocarcinoma, urinary bladder transitional cell carcinoma, invasive ductal breast carcinoma, invasive lobular breast carcinoma, and Hodgkin lymphoma). The results in the PSM-adjusted populations were consistent with outcomes in the multivariable competing risk models. Meanwhile, in subgroup analyses stratified by surgery, some other types of tumor (except for those with positive results in the PSM-adjusted cohorts) with radiotherapy were also associated with a higher prevalence of SPMs in the subgroups of surgical treatment (pancreatic adenocarcinoma, rectal adenocarcinoma, lung adenocarcinoma and follicular thyroid carcinoma in the surgery subgroups). The impact of radiotherapy on the incidence of secondary malignancies is distinct in different types of cancer. These findings merit further investigation and may ultimately impact treatment decision-making for tumor management.

Citing Articles

Risk of second primary cancer in young breast cancer survivors: an important yet overlooked issue.

Liang X, Qin Y, Li P, Mo Y, Chen D Ther Adv Med Oncol. 2025; 17:17588359251321904.

PMID: 40012707 PMC: 11863263. DOI: 10.1177/17588359251321904.


The association between radiotherapy and the prognosis of follicular lymphoma patients with different characteristics in the rituximab era: a cohort study based on Surveillance, Epidemiology and End Results.

Li L, He Z, Zhou Q, Nie B Ann Hematol. 2025; 104(1):691-700.

PMID: 39849163 PMC: 11868175. DOI: 10.1007/s00277-025-06209-0.


Association between radiation therapy for primary endometrial cancer and risk of second primary malignancies: a retrospective cohort study.

Wang Y, Cai Y Sci Rep. 2024; 14(1):24623.

PMID: 39427001 PMC: 11490500. DOI: 10.1038/s41598-024-74840-4.


Impact of radiotherapy on second primary lung cancer incidence and survival in esophageal cancer survivors.

Lu J, Chen D, Shen Z, Gao L, Kang M Sci Rep. 2024; 14(1):17720.

PMID: 39085347 PMC: 11291913. DOI: 10.1038/s41598-024-67753-9.


Second breast cancer: recurrence score results, clinicopathologic characteristics, adjuvant treatments, and outcomes-exploratory analysis of the Clalit registry.

Shachar S, Leviov M, Yerushalmi R, Drumea K, Tokar M, Soussan-Gutman L NPJ Breast Cancer. 2023; 9(1):79.

PMID: 37775723 PMC: 10541873. DOI: 10.1038/s41523-023-00586-3.


References
1.
Abraha I, Aristei C, Palumbo I, Lupattelli M, Trastulli S, Cirocchi R . Preoperative radiotherapy and curative surgery for the management of localised rectal carcinoma. Cochrane Database Syst Rev. 2018; 10:CD002102. PMC: 6517113. DOI: 10.1002/14651858.CD002102.pub3. View

2.
Shiota M, Yokomizo A, Takeuchi A, Inokuchi J, Tatsugami K, Ohga S . Smoking effect on secondary bladder cancer after external beam radiotherapy for prostate cancer. Jpn J Clin Oncol. 2016; 46(10):952-957. DOI: 10.1093/jjco/hyw098. View

3.
Horner-Rieber J, Bernhardt D, Dern J, Konig L, Adeberg S, Paul A . Histology of non-small cell lung cancer predicts the response to stereotactic body radiotherapy. Radiother Oncol. 2017; 125(2):317-324. DOI: 10.1016/j.radonc.2017.08.029. View

4.
Winaikosol K, Surakunprapha P . Rapidly developed Secondary Cutaneous Squamous cell Carcinoma after Post-Surgical Radiation Therapy for Breast Cancer. J Med Assoc Thai. 2018; 99 Suppl 5:S173-6. View

5.
Gensheimer M, Loo Jr B . Optimal Radiation Therapy for Small Cell Lung Cancer. Curr Treat Options Oncol. 2017; 18(4):21. DOI: 10.1007/s11864-017-0467-z. View